Latest Ratios: P/E Ratio -5.7x · EV/EBITDA N/A · ROE -51.8%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $38M | $33M | $36M | $35M | $32M | $22M | $19M | $13M | $5M | $5M | $4M |
| Enterprise Value | $38M | $34M | $39M | $35M | $34M | $22M | $19M | $11M | $5M | $5M | $4M |
| P/E Ratio → | -5.72 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 1.97 | 1.74 | 1.87 | 1.66 | 2.02 | 2.09 | 1.90 | 1.92 | 1.29 | 1.59 | 0.97 |
| P/B Ratio | 2.69 | 2.71 | 3.56 | 2.89 | 3.52 | 6.50 | 6.80 | 3.88 | 9.23 | 8.97 | 6.46 |
| P/FCF | — | — | — | — | — | — | — | — | 65.91 | — | — |
| P/OCF | — | — | — | — | — | 479.33 | — | — | 51.74 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.76 | 2.03 | 1.67 | 2.17 | 2.03 | 1.89 | 1.59 | 1.20 | 1.56 | 0.97 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | 460.06 | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | 61.11 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.8% | 17.8% | 30.3% | 36.8% | 31.4% | 32.2% | 33.9% | 31.2% | 36.7% | 24.5% | 24.1% |
| Operating Margin | -29.1% | -29.1% | -14.3% | -3.0% | -8.6% | -8.5% | -14.3% | -9.0% | -8.6% | -31.8% | -26.9% |
| Net Profit Margin | -30.3% | -30.3% | -15.4% | -0.7% | -5.9% | -1.0% | -14.4% | -9.0% | -8.7% | -31.9% | -26.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -51.8% | -51.8% | -26.7% | -1.4% | -15.0% | -3.3% | -46.4% | -31.2% | -62.6% | -175.7% | -165.0% |
| ROA | -31.5% | -31.5% | -16.1% | -0.8% | -8.1% | -1.6% | -20.6% | -12.3% | -16.3% | -51.3% | -49.7% |
| ROIC | -32.5% | -32.5% | -16.1% | -4.1% | -14.3% | -24.8% | -56.8% | -71.3% | -79.6% | -143.4% | -157.9% |
| ROCE | -43.3% | -43.3% | -20.6% | -4.8% | -17.0% | -26.1% | -40.2% | -27.5% | -60.1% | -166.9% | -164.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.17 | 0.34 | 0.26 | 0.33 | 0.07 | 0.37 | 0.00 | 0.04 | 0.06 | 0.07 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.02 | 0.30 | 0.02 | 0.27 | -0.18 | -0.04 | -0.67 | -0.67 | -0.15 | -0.02 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | -4.80 | — | — |
| Interest Coverage | -24.45 | -24.45 | -12.10 | 0.35 | -4.96 | -18.22 | -1422.98 | -432.59 | -187.53 | -318.83 | -2203.38 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | 1.64 | 1.45 | 1.87 | 1.42 | 1.90 | 1.57 | 1.76 | 1.25 | 1.39 | 1.34 |
| Quick Ratio | 1.06 | 1.06 | 0.87 | 1.35 | 0.76 | 1.15 | 0.87 | 1.28 | 0.66 | 0.53 | 0.59 |
| Cash Ratio | 0.29 | 0.29 | 0.08 | 0.56 | 0.13 | 0.34 | 0.36 | 0.63 | 0.21 | 0.10 | 0.03 |
| Asset Turnover | — | 0.96 | 1.13 | 1.07 | 0.94 | 1.70 | 1.56 | 0.91 | 1.61 | 1.75 | 1.84 |
| Inventory Turnover | 4.40 | 4.40 | 4.64 | 4.79 | 3.56 | 3.84 | 2.99 | 2.70 | 2.23 | 2.26 | 2.62 |
| Days Sales Outstanding | — | 82.91 | 67.74 | 67.77 | 62.02 | 64.24 | 54.49 | 116.14 | 72.03 | 54.21 | 69.93 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | 1.5% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $7M | $6M | $6M | $5M | $4M | $4M | $4M | $3M | $3M | $2M |
Liquidity and scaling constraints
According to current market data, POCI trades at a price-to-sales multiple of 2.14, a valuation that appears disconnected from the company's persistent negative earnings and lack of a forward P/E ratio, suggesting investors are pricing the firm as a speculative turnaround play rather than a stable manufacturer.
The absence of a meaningful P/E or EV/EBITDA ratio reflects the company's inability to generate consistent operating income, forcing reliance on top-line multiples. This valuation level warrants caution, as it implies an expectation of future scale that the current manufacturing footprint has yet to demonstrate.
As reported in recent financial statements, POCI's gross margin has fluctuated significantly, ranging from a low of 2.8% in 2026Q2 to 23.6% in 2026Q3, which highlights the inherent difficulty in maintaining consistent manufacturing efficiency for specialized micro-optical assemblies within a high-fixed-cost environment.
The inability to sustain gross margins above 25% suggests that the company's pricing power is limited by its role as a specialized contract manufacturer. Without a structural shift toward higher-margin proprietary products, the operating margin will likely remain under pressure from the high overhead required for cleanroom operations.
Based on quarterly data, the cash conversion cycle has remained highly erratic, peaking at 115 days in 2025Q1 before compressing to 30 days in 2026Q3, which indicates significant volatility in inventory management and customer collection timing inherent to the company's project-based revenue model.
The wide swings in the cash conversion cycle suggest that POCI struggles to synchronize its production output with customer delivery milestones. Investors should monitor whether the recent compression in the cycle is a sustainable improvement in operational efficiency or merely a temporary artifact of project-specific timing.
As disclosed in recent filings, the company's liquidity position remains vulnerable, with a current ratio that has fluctuated between 1.05 and 2.10 over the last ten quarters, leaving little margin for error given the persistent negative net margins and the ongoing cash burn.
The reliance on external financing to maintain liquidity is evident, as the company's internal cash generation is insufficient to cover operating expenses. This precarious position suggests that any delay in project milestones or unexpected manufacturing scrap could necessitate further dilutive capital raises to ensure operational continuity.
The price-to-sales ratio is frequently misapplied to POCI, as it obscures the company's structural role as a high-end engineering job shop rather than a scalable medical device manufacturer, failing to account for the significant capital intensity required to maintain its specialized cleanroom manufacturing capabilities.
Analysts should instead focus on the NRE-to-production conversion rate and gross margin per assembly, as these metrics better reflect the company's ability to scale. Relying on revenue multiples ignores the reality that POCI's growth is constrained by engineering headcount and facility capacity rather than broad market demand.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying POCI stock.
Precision Optics Corporation, Inc.'s current P/E ratio is -5.7x. The historical average is 16.3x.
Precision Optics Corporation, Inc.'s return on equity (ROE) is -51.8%. The historical average is -74.4%.
Based on historical data, Precision Optics Corporation, Inc. is trading at a P/E of -5.7x. Compare with industry peers and growth rates for a complete picture.
Precision Optics Corporation, Inc. has 17.8% gross margin and -29.1% operating margin.